Tempus AI reports Q2 revenue up 22%, raises guidance, announces $1.5B Personalis acquisition

Filed July 30, 2026 · Period ending July 30, 2026 · ~1 min read

Key Changes

• high

  Q2 revenue $382.5M (+22% YoY) with GAAP net income of $5.6M and Adjusted EBITDA of $8.0M, vs. net loss of $42.8M and negative Adjusted EBITDA of $5.6M in Q2 2025; oncology volume up 31%, Data Licensing & Modeling revenue up 36%.

  Exhibit 99.1 view on EDGAR →
• high

  Raised full-year 2026 revenue guidance to $1.595–$1.605B (~25% growth) and maintained Adjusted EBITDA expectation of ~$65M; guidance excludes impact from pending Personalis acquisition.

  Exhibit 99.1 view on EDGAR →
• high

  Entered definitive agreement to acquire Personalis for $16.25/share (~$1.5B enterprise value) to integrate NeXT Personal MRD technology; transaction expected to close late Q4 2026 or early 2027.

  Exhibit 99.1 view on EDGAR →